2016 Drug Development Organic Chemistry Regulations 
Drug Discovery World
OCTOBER 31, 2023
Professor Andy Whiting and Dr Tony Lockett discuss how specific levels of a protein could be used to advance drug development in neurodegenerative diseases. The UK’s regulator, the MHRA, has indicated support in its early-stage advice, but suggests more clinical data is also needed.
Drug Target Review
JULY 4, 2023
The drivers behind the demand for ADCs Providing more targeted therapeutic options in the oncology space has underpinned the rapid growth of the ADC market; between 2016 to 2020, the US ADC market grew by 45 percent to a value of nearly $1.5 Antibody drug conjugated with cytotoxic payload. Cancer Cell [Internet].
Expert insights. Personalized for you.
147 
Let's personalize your content